CONGENITAL THROMBOPHILIA AS A CAUSE OF THROMBOTIC COMPLICATIONS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Authors

  • Abduganieva Elnora Abralovna
  • Liverko Irina Vladimirovna

Keywords:

chronic obstructive pulmonary disease, thrombophilia, thrombosis, predictors

Abstract

In order to assess the prevalence of polymorphisms of thrombophilia predictor genes and their association with the development of thrombosis in patients with chronic obstructive pulmonary disease, 123 patients with COPD were examined, which were divided into 2 groups according to the presence of thrombosis in their anamnesis (Group 1, patients with COPD without thrombosis in history, n=83 and group 2, patients with a history of thrombosis, n=40). Polymorphisms 20210 G/A of the prothrombin gene, Arg506Gln of the Leiden factor gene, Asp919Gly of the MTR gene, Ala222Val of the MTHFR gene, Glu429Ala of the MTHFR gene, and Ile22Met of the MTRR gene were studied.

The results of the study noted that the studied predictors of thrombophilia were significantly more common in groups of patients with a history of thrombosis. This pattern was established both for polymorphisms of direct strong thrombophilia genes and for indirect thrombophilia genes (hyperhomocysteinemia genes and endothelin-1 genes).

References

Hankey G.J., Eikelboom J.W. Homocysteine and vascular disease. Lancet 1999; 354(9176):407–13.7

Kark J., Selhub J., Adler B. et al. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Int Med 1999;131(5):321–30.9

McIlroy S.P., Dynan K.B., Lawson J.T. et al. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 2002;33(10):2351–6.15

Medina M.F., Urdiales L.L., Amores-Sanchez M.I. Roles of homocysteine cell metabolism. Eur J Biochem 2001;268(14):3871–82.14

Wang X., Duarte N., Cai H. et al. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospitalbased population. Atherosclerosis 1999;146(1):133–40.16

Watkins D., Ru M., Hwang H.Y. et al. Hyperhomocysteinemia due to methionine synthase deficiency, cblG: structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173L. Am J Hum Genet 2002;71(1):143–53.17

Welch G., Loscalo J. Homocysteine and atherosclerosis. New Engl J Med 1998;338(15):1042–50.19

Published

2023-07-16